Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF STOCK OPTIONS (Details)

v3.21.2
SUMMARY OF STOCK OPTIONS (Details)
9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of Options, Beginning Balance | shares 106,120
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 44.32
Weighted Average Remaining Contractual Life (in years), Beginning Balance 4 years 3 months 10 days
Number of Options, Exercised | shares (25,000)
Weighted Average Exercise Price, Exercised | $ / shares $ 2.04
Number of Options, Ending Balance | shares 81,120
Weighted Average Exercise Price, Ending Balance | $ / shares $ 57.35
Weighted Average Remaining Contractual Life (in years), Ending Balance 3 years 9 months
Number of Options Vested and Expected to Vest | shares 81,120
Weighted Average Exercise Price, Options vested and expected to vest | $ / shares $ 57.35
Weighted Average Remaining Contractual Life (in years), Options vested and expected to vest 3 years 9 months
Number of Options Vested and Exercisable | shares 81,120
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | $ / shares $ 57.35
Weighted Average Remaining Contractual Life (in years), Options vested and exercisable 3 years 9 months
Aggregate Intrinsic Value, Outstanding, Ending Balance | $ $ 55,522
Aggregate Intrinsic Value, Exercisable, Ending Balance | $ $ 55,522